检索结果 - Maxim Grymonprez

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

    Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis 由 Maxim Grymonprez, Stéphane Steurbaut, Tine L. De Backer, Mirko Petrović, Lies Lahousse

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis

    Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis 由 Maxim Grymonprez, Cynthia Simoens, Stéphane Steurbaut, Tine L. De Backer, Lies Lahousse

    出版 2021
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

    Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study 由 Maxim Grymonprez, Tine L. De Backer, Xander Bertels, Stéphane Steurbaut, Lies Lahousse

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study

    Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study 由 Maxim Grymonprez, Mirko Petrović, Tine L. De Backer, Stéphane Steurbaut, Lies Lahousse

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

    The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation 由 Maxim Grymonprez, Mirko Petrović, Tine L. De Backer, Stéphane Steurbaut, Lies Lahousse

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study

    Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide coh... 由 Maxim Grymonprez, Laura Carnoy, Andreas Capiau, Koen Boussery, Els Mehuys, Tine L. De Backer, Stéphane Steurbaut, Lies Lahousse

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Chronic obstructive pulmonary disease and the development of atrial fibrillation

    Chronic obstructive pulmonary disease and the development of atrial fibrillation 由 Maxim Grymonprez, Vincent Vakaet, Maryam Kavousi, Bruno H. Stricker, M. Arfan Ikram, Jan Heeringa, Oscar H. Franco, Guy Brusselle, Lies Lahousse

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: